As of September 29, 2026, Camp4 Therapeutics's top three insider holders are Sciences Gp, Llc Enavate (TenPercentOwner, 3.79Mn shares), Andrew J. Schwab (Director, 2.94Mn shares), Partners Vi, Llc 5Am (TenPercentOwner, 2.94Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Sciences Gp, Llc Enavate | TenPercentOwner | 0 | 3,785,802 | 3,785,802 | 26.8% | 17 Oct, 2024 |
| 2 | Partners Vi, Llc 5Am | TenPercentOwner | 0 | 2,941,176 | 2,941,176 | 20.8% | 15 Sep, 2025 |
| 3 | Ventures Ii Gp, Llc Northpond | TenPercentOwner | 0 | 2,238,244 | 2,238,244 | 15.8% | 17 Oct, 2024 |
| 4 | Equity Partners Bio I, L.L.C. Ah | TenPercentOwner | 0 | 2,125,339 | 2,125,339 | 15.0% | 17 Oct, 2024 |
| 5 | Andrew J. Schwab | Director | 0 | 2,033,270 | 2,033,270 | 14.4% | 31 Aug, 2026 |
| 6 | Josh Mandel-Brehm | Chief Executive Officer | 284,968 | 0 | 284,968 | 2.0% | 05 Aug, 2026 |
| 7 | Management Co. Vii, L.L.C. Polaris | TenPercentOwner | 0 | 197,661 | 197,661 | 1.4% | 11 Sep, 2025 |
| 8 | Amir Nashat | Director, TenPercentOwner | 0 | 197,661 | 197,661 | 1.4% | 11 Sep, 2025 |
| 9 | Richard A Young | Director | 186,388 | 0 | 186,388 | 1.3% | 05 Aug, 2026 |
| 10 | Steven H Holtzman | Director | 108,946 | 0 | 108,946 | 0.8% | 15 Oct, 2024 |
| 11 | Yuri Maricich | Chief Medical Officer | 12,611 | 0 | 12,611 | 0.1% | 05 Aug, 2026 |
| 12 | Kelly Gold | Chief Financial Officer | 0 | 10,000 | 10,000 | 0.1% | 02 Sep, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 31 Aug, 2026 | Kelly Gold | Chief Financial Officer | Acquired P | 10,000 | $3.96 | $39.60K | 10,000 | Indirect |
| 27 Aug, 2026 | Andrew J. Schwab | Director | Disposed S | 400,000 | $4.04 | $1.62Mn | 2,033,270 | Indirect |
| 24 Aug, 2026 | Andrew J. Schwab | Director | Disposed S | 10 | $4.50 | $45 | 2,433,270 | Indirect |
| 19 Aug, 2026 | Andrew J. Schwab | Director | Disposed S | 45,147 | $4.76 | $214.90K | 2,579,998 | Indirect |
| 20 Aug, 2026 | Andrew J. Schwab | Director | Disposed S | 114,700 | $4.54 | $520.74K | 2,465,298 | Indirect |
| 21 Aug, 2026 | Andrew J. Schwab | Director | Disposed S | 32,018 | $4.50 | $144.08K | 2,433,280 | Indirect |
| 19 Aug, 2026 | Daniel Tardiff | Chief Scientific Officer | Disposed S | 1,738 | $4.76 | $8.27K | 0 | Direct |
| 03 Aug, 2026 | Richard A Young | Director | Acquired P | 16,378 | $1.65 | $27.02K | 186,388 | Direct |
| 03 Aug, 2026 | Kelly Gold | Chief Financial Officer | Acquired P | 6,551 | $1.65 | $10.81K | 74,428 | Direct |
| 03 Aug, 2026 | Josh Mandel-Brehm | Chief Executive Officer | Acquired P | 6,551 | $1.65 | $10.81K | 284,968 | Direct |
| 03 Aug, 2026 | Partners Vi, Llc 5Am | TenPercentOwner | Acquired P | 3,179,558 | $1.53 | $4.86Mn | 3,179,558 | Indirect |
| 03 Aug, 2026 | Yuri Maricich | Chief Medical Officer | Acquired P | 6,551 | $1.65 | $10.81K | 12,611 | Direct |
| 03 Aug, 2026 | Andrew J. Schwab | Director | Acquired A | 3,179,558 | $1.53 | $4.86Mn | 3,179,558 | Indirect |
| 10 Jun, 2026 | Amir Nashat | Director, TenPercentOwner | Acquired A | 28,000 | $0.00 | $0 | 28,000 | Direct |
| 10 Jun, 2026 | Andrew J. Schwab | Director, TenPercentOwner | Acquired A | 28,000 | $0.00 | $0 | 28,000 | Direct |
| 10 Jun, 2026 | Richard A Young | Director | Acquired A | 28,000 | $0.00 | $0 | 28,000 | Direct |
| 10 Jun, 2026 | Steven H Holtzman | Director | Acquired A | 28,000 | $0.00 | $0 | 28,000 | Direct |
| 10 Jun, 2026 | Murray Stewart | Director | Acquired A | 28,000 | $0.00 | $0 | 28,000 | Direct |
| 10 Jun, 2026 | Douglas E Williams | Director | Acquired A | 28,000 | $0.00 | $0 | 28,000 | Direct |
| 01 Apr, 2026 | Kelly Gold | Chief Financial Officer | Acquired A | 215,000 | $0.00 | $0 | 215,000 | Direct |